Stock Track | Medtronic Plunges 5.06% in Pre-market as Fiscal 2026 Guidance Falls Short of Estimates

Stock Track
02/17

Medtronic PLC's stock fell sharply by 5.06% in pre-market trading, following the release of the company's third-quarter fiscal 2026 financial results and updated guidance.

While the medical device maker reported strong quarterly performance, with adjusted earnings per share of $1.36 beating the IBES estimate of $1.33 and revenue of $9,000 million surpassing the $8,905 million estimate, investors focused on the company's outlook. Medtronic provided fiscal 2026 adjusted EPS guidance in the range of $5.62 to $5.66, which came in below the FactSet consensus estimate of $5.72.

The market's negative reaction highlights investor concerns over the company's future earnings potential, overshadowing the positive third-quarter results that included the highest enterprise revenue growth in ten quarters.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10